Ro wins only when insurance pays the medication, which requires the PA process and the wait cost that comes with it
The 43-year-old tennis star, who broke records and won 23 grand slam titles through her career, was the embodiment of fitness and athletic prowess

Ritual Essential Multivitamin for Women 18+ and 50+ Best for general hormone balance Photo by Innerbody Research Pros All ingredients may positively influence female hormone health Made traceable: all ingredients origins, suppliers, and places of manufacture are detailed Free from major allergens Available in formulas for ages 18+ and 50+ Mint essence masks vitamin-y taste 30% discount on first subscription order Cons One-time purchase options only available through third-party sellers (like Amazon) Boron could worsen endometriosis or other estrogen-sensitive conditions Guarantee doesnt apply to subsequent orders Multivitamin for Women 50+ costs more than the 18+ variant, but without a major formula difference Ritual is a supplement brand that takes a less is more approach to making multivitamins, aiming to give customers only the vitamins and minerals they need to fill in common nutritional gaps

L-Arginine is an amino acid that the body can produce, but it can be obtained through dietary sources, including animal and plant-based foods

HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022SEPTEMBER 2025 TABLE 644 TERNS PHARMACEUTICALS, INC.: COMPANY OVERVIEW TABLE 645 METAVIA: COMPANY OVERVIEW TABLE 646 SCOHIA PHARMA, INC.: COMPANY OVERVIEW TABLE 647 REGOR THERAPEUTICS GROUP: COMPANY OVERVIEW TABLE 648 NEURALY INC.: COMPANY OVERVIEW TABLE 649 I2O THERAPEUTICS, INC.: COMPANY OVERVIEW TABLE 650 PFIZER INC.: COMPANY OVERVIEW TABLE 651 HANMI PHARM CO., LTD.: COMPANY OVERVIEW TABLE 652 JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.: COMPANY OVERVIEW TABLE 653 BIOMED INDUSTRIES, INC.: COMPANY OVERVIEW FIGURE 1 GLP-1 AGONISTS MARKET SEGMENTATION & REGIONAL SCOPE FIGURE 2 GLP-1 AGONISTS MARKET: YEARS CONSIDERED FIGURE 3 GLP-1 AGONISTS MARKET: RESEARCH DESIGN FIGURE 4 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS FIGURE 5 GLP-1 AGONISTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 FIGURE 6 GLP-1 AGONISTS MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2024 FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS FIGURE 8 GLP-1 AGONISTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH FIGURE 9 CAGR PROJECTIONS: GLP-1 AGONISTS MARKET, 20252033 FIGURE 10 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN GLP-1 AGONISTS MARKET FIGURE 11 GLP-1 AGONISTS MARKET: DATA TRIANGULATION METHODOLOGY FIGURE 12 GLP-1 AGONISTS MARKET, BY PRODUCT, 2025 VS

However, in real-world clinical practice, relying solely on lifestyle interventions often fails to achieve sustained and clinically meaningful weight-loss goals, thereby creating a clear role for pharmacological assistance in the management of PCOS-related infertility